2026 Emerging Topic Conference: Unified Frontiers in Liver Disease — Treating Steatosis, Cholestasis, and Beyond | Las Vegas, Nevada | 17.5 AMA PRA Category 1 Credits™ CE Credits

networkED.global

2026 Emerging Topic Conference: Unified Frontiers in Liver Disease — Treating Steatosis, Cholestasis, and Beyond | Las Vegas, Nevada | 17.5 AMA PRA Category 1 Credits™ CE Credits | networkED.global

About This Event

This three-day conference brings together global experts to discuss the latest advances in liver disease care, with a focus on cholestatic liver diseases and steatotic liver disease. Day 1 covers clinical approaches for primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC), while Days 2-3 focus on MASLD, MetALD, noninvasive diagnostics, and therapeutic development. The program is designed to help clinicians and researchers stay at the forefront of evolving liver care science and practice.

Topics Covered

Pain Management

Chronic PainEnd-of-Life / Palliative Care

Neurology Stroke & Brain Injury

Neurodegenerative Diseases

Leadership & Management

Quality Improvement

Addiction & Substance Use

Substance Use Disorders

Venue

Four Seasons Las Vegas

Las Vegas, Nevada

View on Google Maps

Registration & Fees

Regular Registration

465.00

Early Bird Rate

375.00

Registration Opens

Mar 12, 2026

Registration Closes

Mar 14, 2026

Continuing Education

17.5 CE Credits

Accredited by: Accreditation Council for Continuing Medical Education (ACCME)

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Who This Event Is For

Industries

Health & Social Care

Professional Fields

Medical & Direct CareNursing & Advanced PracticePharmacy Professionals

Professions

PhysiciansAdvanced Practice Registered NursesRegistered NursesDietitiansPharmacists

Who Can Attend

Any scientist, physician, or allied health professional, as defined by the Governing Board. This includes individuals residing in the United States, Canada, Mexico, or any other country.

Target Audience

Hepatologists, gastroenterologists, liver transplant specialists, basic and translational scientists in liver disease, clinical researchers, fellows, health care professionals focused on liver care, industry and policy professionals